Vimian Group AB (publ)
SSE:VIMIAN.ST
Overview | Financials
Company Name | Vimian Group AB (publ) |
Symbol | VIMIAN.ST |
Currency | SEK |
Price | 29.12 |
Market Cap | 12,936,268,800 |
Dividend Yield | 0% |
52-week-range | 20.08 - 37.96 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Alireza Tajbakhsh |
Website | https://vimian.com |
An error occurred while fetching data.
About Vimian Group AB (publ)
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD